Targeted therapies for BRAF-mutant melanoma have extended median survival but often lead to drug resistance. Preclinical studies revealed that some resistant melanoma cells exhibit "drug addiction", growing poorly without treatment, suggesting intermittent d... ...

请注册登录后继续浏览